Frontiers in Catecholamine Research. Proceedings of the Third International Catecholamine Symposium Held at the University of Strasbourg, Strasbourg, France May 20–25, 1973

Content: 
Front Matter, Page iii
Copyright, Page iv
INTRODUCTION, Pages 1-24, EARL USDIN, SOLOMON H. SNYDER
Abbreviations, Pages 25-26
THE IMPACT OF MONOAMINE RESEARCH ON DRUG DEVELOPMENT, Pages 27-37, A. PLETSCHER
TWO MECHANISMS OF CATECHOLAMINE STORAGE IN ADRENAL CHROMAFFIN GRANULES, Pages 41-45, A. PLETSCHER, M. DA PRADA, B. LÜTOLD, K.H. BERNEIS, H. STEFFEN, H.G. WEDER
PROPERTIES OF TYROSINE HYDROXYLASE, Pages 47-52, JOSÉ M. MUSACCHIO, GALE L. CRAVISO
COFACTORS OF TYROSINE HYDROXYLASE, Pages 53-60, SEYMOUR KAUFMAN
CHARACTERISATION OF DOPA DECARBOXYLASE, Pages 61-67, WALLACE DAIRMAN, JAMES CHRISTENSON, SIDNEY UDENFRIEND
CHARACTERISATION, LOCALISATION AND REGULATION OF CATECHOLAMINE SYNTHESIZING ENZYMES, Pages 69-78, MENEK GOLDSTEIN, BERTA ANAGNOSTE, LEWIS S. FREEDMAN, MARK ROFFMAN, RICHARD P. EBSTEIN, DONG H. PARK, KJELL FUXE, TOMAS HÖKFELT
IMMUNOLOGICAL LOCALISATION OF DOPAMINE-β-HYDROXYLASE ON THE CHROMAFFIN GRANULE MEMBRANE, Pages 79-81, JAMES A. THOMAS, IRWIN J. KOPIN, L.S. VAN ORDEN III, J.A. REDICK
NEW INHIBITORS OF MICROBIAL ORIGIN FOR DOPAMINE-β-HYDROXYLASE, Pages 83-86, TOSHIHARU NAGATSU, TAKESHI KATO, HIROSHI KUZUYA, HAMAO UMEZAWA, TOMIO TAKEUCHI
PICOLINIC ACID DERIVATIVES AS INHIBITORS OF DOPAMINE β-HYDROXYLASE IN VIVO; THEIR EFFECTS ON BLOOD PRESSURE AND STRESS ULCER, Pages 87-88,88a,89-90, HIROYOSHI HIDAKA
THE INNERVATION OF CEREBRAL BLOOD VESSELS BY CENTRAL NORADRENERGIC NEURONS, Pages 91-96, BOYD K. HARTMAN
COMPARATIVE STUDIES ON BOVINE AND GUINEA PIG TYROSINE HYDROXYLASE, Pages 97-100, BARBARA PETRACK, VALENTINA FETZER, RALPH ALTIERE
REGULATION OF PHENYLETHANOLAMINE N-METHYLTRANSFERASE, Pages 101-105, ROLAND D. CIARANELLO
CATECHOL-O-METHYLTRANSFERASE, Pages 107-112, C. BOHUON, M. ASSICOT
THE CELLULAR LOCALISATION AND PHYSIOLOGICAL ROLE OF CATECHOL-O-METHYL TRANSFERASE IN THE BODY, Pages 113-115, BEVYN JARROTT
IMMUNOLOGICAL CHARACTERIZATION OF CATECHOL-O-METHYLTRANSFERASE, Pages 117-119, C.R. CREVELING, R.T. BORCHARDT, C. ISERSKY
NEW CONCEPTS ON THE N-METHYLATION REACTIONS OF BIOGENIC AMINES IN ADRENAL MEDULLA AND BRAIN, Pages 121-128, PIERRE LADURON
RINGDEHYDROXYLATION AND N-METHYLATION OF NORADRENALINE AND DOPAMINE IN THE INTACT RAT BRAIN, Pages 129-131, K. BRANDAU, J. AXELROD
DEGRADATION OF THE TRANSMITTER AMINES BY SPECIFIC TYPES OF MONOAMINE OXIDASES, Pages 133-137, N.H. NEFF, H.-Y.T. YANG, C. GORIDIS
THE IMPORTANCE OF THE ‘HYDROXYLAMINE METABOLIC ROUTE’ IN PHARMACOLOGY, TOXICOLOGY AND PHARMACOKINETICS, Pages 139-143, ARNOLD H. BECKETT
SOME CHARACTERISTICS OF RAT LIVER MITOCHONDRIAL MONOAMINE OXIDASES, Pages 145-146, A. D\'IORIO, J.M. DIAZ BORGES, C. KANDASWAMI
THE NATURE OF THE ELECTROPHORETICALLY SEPARABLE FORMS OF MONOAMINE OXIDASE, Pages 147-149, MILES D. HOUSLAY, KEITH F. TIPTON
TRANSFORMATION OF MONOAMINE OXIDASES AND DEAMINATION OF FATTY-AROMATIC MONOAMINES, Pages 151-152, V.Z. GORKIN
ON THE MECHANISM OF INHIBITION OF MONOAMINE OXIDASE, Pages 153-155, E.A. ZELLER, M. HSU
SELECTIVE LOCALISATION OF MONOAMINE OXIDASE FORMS IN RAT MESENTERIC ARTERY, Pages 157-160, C. GORIDIS, N.H. NEFF
OXIDATIVE-REDUCTIVE PATHWAYS FOR METABOLISM OF BIOGENIC ALDEHYDES, Pages 161-166, V. GENE ERWIN
SULFATE CONJUGATES IN THE BRAIN, Pages 167-171, J.L. MEEK, A. FOLDES
REPORTER\'S NOTES—FIRST SESSION, Pages 173-174, O.T. PHILLIPSON DR.
REPORTER\'S NOTES—SECOND SESSION, Pages 175-176, MOUSSA B.H. YOUDIM
TRANS-SYNAPTIC REGULATION OF TYROSINE HYDROXYLASE, Pages 179-185, HANS THOENEN, UWE OTTEN, FRANZ OESCH
MODULATION OF ADRENAL TYROSINE HYDROXYLASE INDUCTION BY SEROTONIN NERVE FUNCTION, Pages 187-189, R.A. MUELLER, R.D. SMITH, G.R. BREESE, B.R. COOPER
ROLE OF CATECHOLAMINES IN INDUCTION OF ADRENAL TYROSINE HYDROXYLASE, Pages 191-193, B. BHAGAT
DOPAMINE-β-HYDROXYLASE AND THE REGULATION OF CATECHOLAMINE BIOSYNTHESIS, Pages 195-200, PERRY B. MOLINOFF, JAMES C. ORCUTT
RETROGRADE AXONAL TRANSPORT OF DOPAMINE-β-HYDROXYLASE, Pages 201-203, STEPHEN BRIMIJOIN
GROWTH AND DEVELOPMENT OF A SYMPATHETIC GANGLION IN VIVO, Pages 205-210, IRA B. BLACK
STUDIES ON THE MECHANISM OF REGULATION OF TYROSINE HYDROXYLASE ACTIVITY DURING NERVE STIMULATION, Pages 211-221, N. WEINER, R. BJUR, F.-L. LEE, G. BECKER, W.F. MOSIMANN
TRANSSYNAPTIC AND HUMORAL REGULATION OF ADRENAL CATECHOLAMINE SYNTHESIS IN STRESS, Pages 223-229, RICHARD KVETŇANSKÝ
TRANSSYNAPTIC REGULATION OF TYROSINE HYDROXYLASE IN ADRENAL MEDULLA: POSSIBLE ROLE OF CYCLIC NUCLEOTIDES, Pages 231-236, A. GUIDOTTI, C.C. MAO, E. COSTA
COMMENT—CHOLINERGIC REGULATION OF TYROSINE HYDROXYLASE, Page 237, J.S. RICHARDSON
SYMPATHETIC GANGLIA IN CULTURE, Pages 239-244, IRWIN J. KOPIN, KENNETH R. BERV, JERRY G. WEBB
LACK OF RELATIONSHIP BETWEEN NORADRENALINE CONTENT AND TYROSINE HYDROXYLASE ACTIVITY IN CULTURED SYMPATHETIC GANGLIA, Pages 245-248, A.V.P. MACKAY, L.L. IVERSEN
INDUCTION OF TYROSINE HYDROXYLASE IN SUPERIOR CERVICAL GANGLION BY COLD EXPOSURE: EFFECTS OF DECENTRALISATION AND MECAMYLAMINE, Pages 249-251, INGEBORG HANBAUER
REGULATION OF CATECHOL SYNTHESIS IN AN ADRENERGIC CLONE OF MOUSE NEUROBLASTOMA, Pages 253-259, ELLIOTT RICHELSON
DEVELOPMENT OF THE CENTRAL CATECHOLAMINERGIC NEURONS OF THE RAT, Pages 261-265, JOSEPH T. COYLE
INTERACTION BETWEEN THE NERVE GROWTH FACTOR (NGF) AND ADRENERGIC BLOCKING AGENTS IN SYMPATHETIC NEURONS, Pages 267-276, RITA LEVI-MONTALCINI, LUIGI ALOE, EUGENE M. JOHNSON JR.
NEUROBLASTOMA CELLS AS A TOOL FOR NEURONAL MOLECULAR BIOLOGY, Pages 277-283, P. MANDEL, J. CIESIELSKI-TRESKA, J.C. HERMETET, J. ZWILLER, G. MACK, C. GORIDIS
REPORTER\'S NOTES, Pages 285-288, NORMAN WEINER
THE CLASSIFICATION OF ADRENERGIC RECEPTORS, Pages 291-294, NEIL C. MORAN
ANTAGONISM OF PROPRANOLOL TO ISOPROTERENOL IN GUINEA-PIG TRACHEA: SOME CAUTIONARY FINDINGS, Pages 295-299, ROBERT F. FURCHGOTT, ARON JURKIEWICZ, N.H. JURKIEWICZ
REGULATION OF CYCLIC AMP LEVELS IN BRAIN, Pages 301-306, JOHN W. DALY
REGULATION OF ADENOSINE 3′,5′-CYCLIC MONOPHOSPHATE METABOLISM IN HYBRID SOMATIC CELLS, Pages 307-310, ALFRED G. GILMAN, JOHN D. MINNA
ONTOGENETIC DEVELOPMENT OF THE CATECHOLAMINE-SENSITIVE ADENYL CYCLASE ACTIVITY OF RAT CEREBRAL CORTEX, Pages 311-313, JOHN P. PERKINS, MARILYN M. MOORE
ROLE OF β-ADRENERGIC RECEPTOR IN THE CONTROL OF SEROTONIN N-ACETYLTRANSFERASE IN RAT PINEAL, Pages 315-319, TAKEO DEGUCHI, JULIUS AXELROD
BETA-ADRENERGIC REGULATION OF INDOLE METABOLISM IN THE PINEAL GLAND, Pages 321-325, DAVID C. KLEIN, ARTHUR YUWILER
SELECTIVE REGULATION OF THE MULTIPLE FORMS OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE BY NOREPINEPHRINE AND OTHER AGENTS, Pages 327-333, BENJAMIN WEISS
STEREOISOMERS OF CATECHOLAMINES, Pages 335-337, P.N. PATIL
EFFECTS OF CATECHOLAMINES AND PROSTAGLANDINS ON CYCLIC AMP LEVELS IN BRAIN IN VIVO, Pages 339-343, ERIK WESTERMANN
DEVELOPMENT OF ANTIBODIES AGAINST CATECHOLAMINES, Pages 345-349, SYDNEY SPECTOR, COLIN DALTON, ARTHUR M. FELIX
METABOLIC RESPONSES OF CARDIAC, SKELETAL MUSCLE, AND FAT CELLS TO CATECHOLAMINES, Pages 351-356, STEVEN E. MAYER
METHODS OF APPROACH FOR THE ISOLATION OF β-ADRENERGIC RECEPTORS, Pages 357-360, P.B. MOLINOFF
TOWARD ISOLATION OF A β-ADRENERGIC BINDING PROTEIN, Pages 361-368, ROBERT J. LEFKOWITZ, M.D.
RECENT ADVANCES IN THE ACTIVE SITE CHEMISTRY OF THE ADRENERGIC ALPHA-RECEPTOR, Pages 369-371, BRUCE LIPPERT, B. BELLEAU
OPERATION OF TWO EPINEPHRINE RECEPTORS AND AN ACETYLCHOLINE RECEPTOR IN THE EXOCRINE CELL OF THE RAT PAROTID GLAND, Pages 373-376, MICHAEL SCHRAMM, ZVI SELINGER
DOPAMINE-, OCTOPAMINE-, AND SEROTONIN-SENSITIVE ADENYLATE CYCLASES: POSSIBLE RECEPTORS IN AMINERGIC NEUROTRANSMISSION, Pages 377-382, PAUL GREENGARD, JAMES A. NATHANSON, JOHN W. KEBABIAN
COMPARISON OF THE EXCITATORY ACTION OF ACETYLCHOLINE AND NORADRENALINE ON THE GUINEA-PIG MYOMETRIUM, Pages 383-388, JOSEPH H. SZURSZEWSKI
POSSIBLE MECHANISM OF THE ACTION OF CATECHOLAMINES ON SMOOTH MUSCLE, Pages 389-391, EDITH BÜLBRING
REPORTER\'S NOTES, Pages 393-395, G.A. ROBISON
CHAIRMAN\'S REMARKS, Pages 399-400, U.S. VON EULER
CATECHOLAMINE RELEASE AND MOBILISATION OF PROTEIN, Pages 401-402, H. BLASCHKO
NEURONAL AND EXTRANEURONAL CATECHOLAMINE UPTAKE MECHANISMS, Pages 403-408, L.L. IVERSEN
THE POSSIBLE IMPORTANCE OF YOUNG (LARGE) AMINE STORAGE GRANULES FOR ADRENERGIC NERVE TERMINAL FUNCTION, Pages 409-410, ANNICA DAHLSTRÖM, JAN HÄGGENDAL
CONFORMATIONAL ASPECTS OF THE INHIBITION OF NEURONAL UPTAKE OF NORADRENALINE BY TRICYCLIC ANTIDEPRESSANTS, Pages 411-413, A.S. HORN
COMPOSITION AND MOLECULAR ORGANISATION OF CHROMAFFIN GRANULES, Pages 415-421, H. WINKLER, HEIDE HÖRTNAGL
A LARGE SECOND POOL OF NOREPINEPHRINE IN THE HIGHLY PURIFIED VESICLE FRACTION FROM BOVINE SPLENIC NERVE, Pages 423-425, RICHARD L. KLEIN
EFFECT OF ELECTROLYTES ON AMINE TRANSPORT AND RELEASE MECHANISMS IN NERVE ENDINGS, Pages 427-429, DONALD F. BOGDANSKI
SMALL INTENSELY FLUORESCENT (SIF) CELLS IN VIVO AND IN VITRO, Pages 431-437, OLAVI ERÄNKÖ, LISA ERÄNKÖ
NEURONAL CATECHOLAMINE STORAGE VESICLES, Pages 439-446, TOMAS HÖKFELT
SECRETION AND RECOVERY OF CATECHOLAMINES BY THE ADRENAL MEDULLA, Pages 447-452, N. KIRSHNER, T.A. SLOTKIN
NEW ASPECTS OF THE LOCALISATION OF CATECHOLAMINES IN ADRENERGIC NEURONS, Pages 453-458, J.P. TRANZER
PLASTIC CHANGES OF CENTRAL NORADRENALINE NEURONS AFTER 6-HYDROXYDOPAMINE, Pages 459-461, GÖSTA JONSSON, CHRIS PYCOCK, CHARLOTTE SACHS
CHARACTERISATION OF CORTICAL NORADRENERGIC AXON TERMINALS WITH HIGH RESOLUTION RADIOAUTOGRAPHY, Pages 463-465, LAURENT DESCARRIES, YVES LAPIERRE
MATRIX PHASE ORGANISATION IN THE ADRENAL CHROMAFFIN GRANULE, Pages 467-469, K.B. HELLE, G. SERCK-HANSSEN
RELEASE OF AMINES FROM SYMPATHETIC NERVES, Pages 471-475, W.P. DE POTTER
MECHANISMS OF EXOCYTOSIS, Pages 477-482, ALAN M. POISNER
IMMUNOLOGICAL STUDIES OF DOPAMINE β-HYDROXYLASE AS A MARKER FOR ADRENERGIC SYNAPTIC VESICLES, Pages 483-489, L.B. GEFFEN, R.A. RUSH
MECHANISMS OF CATECHOLAMINE SECRETION DUAL FEEDBACK CONTROL OF SYMPATHETIC NEUROTRANSMITTER SECRETION; RÔLE OF CALCIUM, Pages 491-496, L. STJÄRNE
THE EFFECT OF TRANSMITTER RELEASE ON THE DOPAMINE β HYDROXYLASE CONTENT OF SYMPATHETIC NERVE TERMINALS, Pages 497-499, MARIANNE FILLENZ, D.P. WEST
PHOSPHOLIPIDS OF THE CHROMAFFIN GRANULE MEMBRANE AND CATECHOLAMINE RELEASE, Pages 501-503, J.M. TRIFARÓ
EXOCYTOSIS AT SYMPATHETIC NERVE TERMINALS, Pages 505-507, G. FREDERICK WOOTEN
ON THE DYNAMICS OF CATECHOLAMINES STORAGE STRUCTURES IN SYMPATHETIC NEURONS OF THE RAT AS STUDIED BY RADIOAUTOGRAPHY, Pages 509-511, JACQUES TAXI, CONSTANTINO SOTELO
NEW INVESTIGATIONS OF THE CARDIOVASCULAR ACTIONS OF DOPAMINE, Pages 513-521, LEON I. GOLDBERG, T. BUDYA TJANDRAMAGA, AARON H. ANTON, NOBORU TODA
DRUG ACTIONS ON α-METHYL-m-TYRAMINE, A FALSE DOPAMINERGIC TRANSMITTER IN THE RAT STRIATUM, Pages 523-526, P.A. SHORE, R.L. DORRIS
EXTRANEURONAL UPTAKE OF CATECHOLAMINES*, Pages 527-530, U. TRENDELENBURG
REGULATION OF CATECHOLAMINE RELEASE, Pages 531-535, JAN HÄGGENDAL
REGULATION OF CATECHOLAMINE RELEASE. THE MUSCARINIC INHIBITORY MECHANISM, Pages 537-542, E. MUSCHOLL
THE REGULATION OF TRANSMITTER RELEASE ELICITED BY NERVE STIMULATION THROUGH A PRESYNAPTIC FEED-BACK MECHANISM, Pages 543-549, S.Z. LANGER
THE NEUROGENIC SHORT-TERM CONTROL OF CATECHOLAMINE SYNTHESIS AND RELEASE IN THE SYMPATHO-ADRENAL SYSTEM, AS REFLECTED IN THE LEVELS OF ENDOGENOUS DOPAMINE AND β-HYDROXYLATED CATECHOLAMINES, Pages 551-556, A. CARISSON, S.R. SNIDER, O. ALMGREN, M. LINDQVIST
IN VIVO RELEASE OF 3H-DA FROM THE CAT CAUDATE NUCLEUS, Pages 557-559, M.J. BESSON, A. CHERAMY, J. GLOWINSKI, C. GAUCHY
REGULATION OF CATECHOLAMINE RELEASE: α-RECEPTOR MEDIATED FEED-BACK CONTROL IN PERIPHERAL AND CENTRAL NEURONES, Pages 561-565, KLAUS STARKE
EFFECT OF IMPULSE FLOW ON THE RELEASE AND SYNTHESIS OF DOPAMINE IN THE RAT STRIATUM, Pages 567-574, ROBERT H. ROTH, JUDITH R. WALTERS, GEORGE K. AGHAJANIAN
EFFECTIVENESS OF ADRENERGIC TRANSMITTER CONCENTRATIONS IN SYNAPTIC CLEFTS OF DIFFERING DIMENSIONS, Pages 575-577, JOHN A. BEVAN, CHE SU
PULSE-TO-PULSE MODULATION OF NORADRENALINE RELEASE THROUGH A PREJUNCTIONAL α-RECEPTOR AUTO-INHIBITORY MECHANISM, Pages 579-581, M.J. RAND, D.F. STORY, G.S. ALLEN, A.B. GLOVER, M.W. MCCULLOCH
ASPECTS ON PROSTAGLANDIN AND α-RECEPTOR MEDIATED CONTROL OF TRANSMITTER RELEASE FROM ADRENERGIC NERVES, Pages 583-587, PER HEDQVIST
CATECHOLAMINE RELEASE AND RECEPTORS IN BRAIN SLICES, Pages 589-593, LARS-OVE FARNEBO, BERTIL HAMBERGER
RECEPTOR REGULATION STUDIES: SIGNIFICANCE OF CENTRAL CATECHOLAMINE RECEPTORS IN CARDIOVASCULAR CONTROL, Pages 595-600, MATTS HENNING
RECEPTOR REGULATION OF DOPAMINE TURNOVER, Pages 601-604, HENRIK NYBÄCK, FRITS-AXEL WIESEL, GÖRAN SEDVALL
REGULATION OF DA SYNTHESIS IN THE NIGRO NEOSTRIATAL SYSTEM, Pages 605-611, J. GLOWINSKI, Y. AGID, M.J. BESSON, A. CHÉRAMY, C. GAUCHY, F. JAVOY
SYNTHESIS AND PREFERENTIAL RELEASE OF NEWLY FORMED NOREPINEPHRINE DURING INCREASED SYMPATHETIC ACTIVITY, Pages 613-614, NGUYEN B. THOA
DECENTRALISATION INCREASES NORADRENALINE RELEASE FROM FIELD-STIMULATED RAT IRIDES, Pages 615-616, BERTIL HAMBERGER, LARS-OVE FARNEBO
EFFECT OF ACETYLCHOLINE ON THE RELEASE OF 3H-NOREPINEPHRINE BY NICOTINE AND POTASSIUM CHLORIDE FROM RAT BRAIN SLICES, Pages 617-618, THOMAS C. WESTFALL
REPORTER\'S NOTES—FIRST SESSION, Pages 619-621, ROSS J. BALDESSARINI
REPORTER\'S NOTES, Page 623, BERTIL HAMBERGER
INTRODUCTORY REMARKS: REGIONAL ECONOMY AND FAMILIES OF NEUROREGULATORY SUBSTANCES, Pages 627-632, JOEL ELKES
CHAIRMAN\'S INTRODUCTORY REMARKS, Pages 633-634, MARTHE VOGT
CENTRAL CATECHOLAMINES AND HYPERTENSION, Pages 635-636, ALBERT SJOERDSMA
NOREPINEPHRINE AS A CENTRAL SYNAPTIC TRANSMITTER, Pages 637-642, FLOYD E. BLOOM, BARRY J. HOFFER
CENTRAL DOPAMINERGIC NEURONS: NEUROPHYSIOLOGICAL IDENTIFICATION AND RESPONSES TO DRUGS, Pages 643-648, GEORGE K. AGHAJANIAN, BENJAMIN S. BUNNEY
EXISTENCE OF DOPAMINERGIC NERVE TERMINALS IN THE RAT CORTEX, Pages 649-651, A.M. THIERRY, J. GLOWINSKI
EXCITATORY EFFECTS OF CATECHOLAMINES IN THE C.N.S., Pages 653-656, P.B. BRADLEY
GENETIC FACTORS IN THE CONTROL OF BRAIN LEVELS OF BIOGENIC AMINES AND BRAIN EXCITABILITY, Pages 657-659, G.M. EVERETT
CATECHOLAMINE RECEPTOR MECHANISMS IN VERTEBRATES, Pages 661-665, NILS-ERIK ANDÉN
EXCITATORY EFFECTS OF DOPAMINE ON MOLLUSCAN NEURONES, Pages 667-671, P. ASCHER
ANALYSIS OF DOPAMINE SPECIFIC, EXCITATORY AND INHIBITORY ACTIONS ON NEURONS OF THE SNAIL, Pages 673-674, H.A.J. STRUYKER BOUDIER, W. GIELEN, J.M. VAN ROSSUM
DOPAMINERGIC TRANSMISSION IN RELATION TO MECHANISMS UNDERLYING STEREOTYPED BEHAVIOUR, Pages 675-676, C.L.E. BROEKKAMP, A.J.J. PIJNENBURG, J.M. VAN ROSSUM
HISTOCHEMICAL DEMONSTRATION OF MONOAMINE NEURON SYSTEMS IN THE HUMAN FETAL BRAIN, Pages 677-681, ANDERS NOBIN, ANDERS BJÖRKLUND
GLYOXYLIC ACID CONDENSATION: A NEW FLUORESCENCE HISTOCHEMICAL METHOD FOR SENSITIVE AND DETAILED TRACING OF CENTRAL CATECHOLAMINE NEURONS, Pages 683-687, OLLE LINDVALL, ANDERS BJÖRKLUND, BENGT FALCK
BEHAVIOURAL-ANATOMICAL CORRELATES OF CENTRAL CATECHOLAMINE NEURONS, Pages 689-693, U. UNGERSTEDT, T. LJUNGBERG
BEHAVIOURAL PHARMACOLOGY OF 6-HYDROXYDOPAMINE, Pages 695-700, R.I. SCHOENFELD, M.J. ZIGMOND
BIOCHEMICAL AND BEHAVIOURAL ALTERATIONS FOLLOWING 6-HYDROXYDOPAMINE ADMINISTRATION INTO BRAIN, Pages 701-706, GEORGE R. BREESE, BARRETT R. COOPER, RONALD D. SMITH
INHIBITION OF THE BLOOD PRESSURE RESPONSE TO α-METHYLDOPA IN UNANESTHETIZED RENAL HYPERTENSIVE RATS BY NEONATAL 6-HYDROXYDOPAMINE (6-OHDA) TREATMENT, Pages 707-708, WYBREN DE JONG, ABRAHAM P. PROVOOST, FRANS P. NIJKAMP
BIOGENIC AMINES AND THEIR METABOLISM IN THE STUDY OF AGGRESSIVE BEHAVIOUR IN RATS, Pages 709-710, BURR EICHELMAN
BRAIN NOREPINEPHRINE AND INGESTIVE BEHAVIOUR, Pages 711-713, SARAH FRYER LEIBOWITZ
EFFECTS ON FEEDING BEHAVIOUR AFTER INTRAHYPOTHALAMIC INJECTIONS OF 6-HYDROXY-DOPAMINE IN RATS, Pages 715-717, JOSEPH L. SLANGEN
BRAIN STEM NOREPINEPHRINE: BEHAVIOURAL AND BIOCHEMICAL DIFFERENTIATION OF RESPONSES TO FOOTSHOCK IN RATS, Pages 719-722, JON M. STOLK, JACK D. BARCHAS
THE COERULO-CORTICAL NOREPINEPHRINE SYSTEM AND LEARNING, Pages 723-726, T.J. CROW
ELECTRICAL SELF-STIMULATION IN THE LOCUS COERULEUS AND NOREPINEPHRINE TURNOVER IN CEREBRAL CORTEX, Pages 727-728, T.J. CROW
EFFECTS OF 6-HYDROXYDOPA, Pages 729-739, DAVID M. JACOBOWITZ
CHOLINERGIC-DOPAMINERGIC RELATION IN DIFFERENT BRAIN STRUCTURES, Pages 741-745, G. BARTHOLINI, H. STADLER, K.G. LLOYD
CHANGES IN STRIATAL DA METABOLISM INDUCED BY CHOLINERGIC AND ANTICHOLINERGIC NIGRAL STIMULATION IN THE RAT, Pages 747-749, F. JAVOY, Y. AGID, J. GLOWINSKI
ROLE OF CATECHOLAMINES IN THE CONTROL OF THE SLEEP-WAKING CYCLE, Pages 751-757, MICHEL JOUVET
CATECHOLAMINE MECHANISMS: THEIR PRESUMPTIVE ROLE IN THE GENERATION OF REM SLEEP PGO WAVES, Pages 759-762, STEVEN HENRIKSEN, BARRY JACOBS, WILLIAM DEMENT, JACK BARCHAS
EFFECTS ON PRECISE MOTOR RESPONDING OF BILATERAL 6-HYDROXYDOPAMINE INFUSION INTO THE SUBSTANTIA NIGRA, Pages 763-766, LARRY L. BUTCHER, GORDON K. HODGE, GUY K. BRYAN, SHEILA M. EASTGATE
TELENCEPHALIC DISTRIBUTION OF TERMINALS OF BRAINSTEM NOREPINEPHRINE NEURONS, Pages 767-769, ROBERT Y. MOORE
BIOCHEMICAL EVIDENCES FOR INTERACTION PHENOMENA BETWEEN NORADRENERGIC AND SEROTONINERGIC SYSTEMS IN THE CAT BRAIN, Pages 771-772, J.F. PUJOL, D. STEIN, CH. BLONDAUX, F. PETITJEAN, J.L. FROMENT, M. JOUVET
NE-NEURONS AND PHASIC SLEEP PHENOMENA, Pages 773-775, W. HAEFELY, M. JALFRE, M.-A. MONACHON
DOPAMINE AND ACETYLCHOLINE NEURONES IN STRIATAL AND LIMBIC STRUCTURES: EFFECT OF NEUROLEPTIC DRUGS, Pages 777-779, K.G. LLOYD, H. STADLER, G. BARTHOLINI
ROLE OF CATECHOLAMINES IN NEUROENDOCRINE FUNCTION, Pages 781-785, R.J. WURTMAN
RECENT MORPHOLOGICAL AND FUNCTIONAL STUDIES ON HYPOTHALAMIC DOPAMINERGIC AND NORADRENERGIC MECHANISMS, Pages 787-794, KJELL FUXE, TOMAS HÖKFELT, GÖSTA JONSSON, ANDERS LÖFSTRÖM
EFFECT OF PREGNANCY AND SEX HORMONES ON THE TRANSMITTER LEVEL IN UTERINE SHORT ADRENERGIC NEURONS, Pages 795-801, CH. OWMAN, N.-O. SJÖBERG
CATECHOLAMINES IN SEXUAL HORMONE REGULATION: FOREBRAIN INFLUENCE ON TUBERO-INFUNDIBULAR DOPAMINE NEURONS AND INTERACTION WITH CHOLINERGIC SYSTEMS, Pages 803-809, W. LICHTENSTEIGER
EFFECTS OF CATECHOLAMINES ON SUPRA-OPTIC NUCLEUS NEURONES IN ORGAN CULTURE, Pages 811-813, BERNARD H. MARKS, KAKUICHI K. SAKAI, JACK M. GEORGE, ADALBERT KOESTNER
CATECHOLAMINES IN NON-NEURAL CELLS OF THE CNS: A POSSIBILITY, Pages 815-817, WILLIAM J. SHOEMAKER
CATECHOLAMINES AND THE SECRETION OF RENIN, ACTH AND GROWTH HORMONE, Pages 819-824, WILLIAM F. GANONG
L-DOPA AND PANCREATIC SECRETION, Pages 825-829, KOROKU HASHIMOTO, YASUHIKO FURUTA, KAZUHIKO IWATSUKI
CATECHOLAMINE BIOSYNTHETIC ENZYMES IN PANCREATIC ISLET CELLS, Pages 831-833, HAROLD E. LEBOVITZ, ROBERT W. DOWNS Jr.
BRAIN MONOAMINES PARTICIPATION IN THE CONTROL OF GROWTH HORMONE SECRETION IN DIFFERENT ANIMAL SPECIES, Pages 835-841, EUGENIO E. MÜLLER
EFFECTS OF L-DOPA ON PROLACTIN SECRETION IN HUMANS, Pages 843-847, ANDREW G. FRANTZ, HAN K. SUH, GORDON L. NOEL
HYPOTHALAMIC CATECHOLAMINES (CA) AND THE SECRETION OF GONADOTROPINS AND GONADOTROPIN RELEASING HORMONES, Pages 849-852, I.A. KAMBERI
THE MECHANISM OF ACTION OF CLONIDINE, Pages 853-857, R. BLOCH, P. BOUSQUET, J. FELDMAN, J. SCHWARTZ
ROLE OF SYMPATHETIC FIBRES AND OF ADRENAL MEDULLA IN THE MAINTENANCE OF CARDIOVASCULAR HOMEOSTASIS IN NORMOTENSIVE AND HYPERTENSIVE RATS, Pages 859-864, JACQUES DE CHAMPLAIN, MARIE-REINE VAN AMERINGEN
SODIUM AND CATECHOLAMINE EXCRETION, Pages 865-866, YEHUDA GUTMAN, GIORA FEUERSTEIN, PUNYA BOONYAVIROJ
HYPERTENSION, ANTIHYPERTENSIVE DRUGS, AND NOREPINEPHRINE IN BLOOD VESSELS, Pages 867-873, BARRY BERKOWITZ, TRAJKO TRAJKOV, JAMES TARVER, SYDNEY SPECTOR
INTRACISTERNAL 6-HYDROXYDOPAMINE (6-OHDA) AND 5,6 DIHYDROXYTRYPTAMINE (5,6-DHT) IN EXPERIMENTAL HYPERTENSION, Pages 875-877, J.P. CHALMERS, J.L. REID, L.M.H. WING
CENTRAL ADRENERGIC NEURONS AND THE CONTROL OF BLOOD PRESSURE, Pages 879-881, G. HAEUSLER
THE CENTRAL NEURAL REGULATION BY BARORECEPTORS OF PERIPHERAL CATECHOLAMINERGIC MECHANISMS, Pages 883-889, DONALD J. REIS, NOBUTAKA DOBA, M. SAMIR AMER
GENETIC VARIATION OF THE CATECHOLAMINE BIOSYNTHETIC ENZYME ACTIVITIES IN VARIOUS STRAINS OF RATS INCLUDING THE SPONTANEOUSLY HYPERTENSIVE RAT, Pages 891-895, WALTER LOVENBERG, HIROHIKO YAMABE, WYBREN DE JONG, CARL T. HANSEN
NOREPINEPHRINE SYNTHESIS AND TURNOVER IN THE BRAIN: ACCELERATION BY PHYSOSTIGMINE, Pages 897-899, TOMISLAV KAŽIĆ
AMINOACYL DERIVATIVES OF DOPAMINE AS ORALLY EFFECTIVE RENAL VASODILATORS, Pages 901-903, J.H. BIEL, P. SOMANI, P.H. JONES, F.N. MINARD, L.I. GOLDBERG
REPORTER\'S NOTES—FIRST SESSION, Pages 905-906, BARRY HOFFER
REPORTER\'S NOTES, Page 907, M. SANDLER
CLINICAL PHARMACOLOGICAL STUDY AND EEG CHANGES OF DELTA-9 TETRAHYDROCANNABINOL EFFECTS IN HUMAN VOLUNTEERS, Pages 911-915, J.R. BOISSIER
AMPHETAMINE AND COCAINE ON AMINE TURNOVER, Pages 917-925, A. GROPPETTI, F. ZAMBOTTI, A. BIAZZI, P. MANTEGAZZA
COMPARATIVE METABOLISM OF SOME AMPHETAMINES IN VARIOUS SPECIES, Pages 927-932, R.T. WILLIAMS, J. CALDWELL, L.G. DRING
BEHAVIOURAL PHARMACOLOGY OF D-AMPHETAMINE: SOME METABOLIC AND PHARMACOLOGICAL CONSIDERATIONS, Pages 933-937, H.C. FIBIGER
CATECHOLAMINE METABOLISM AND AMPHETAMINE EFFECTS ON SENSITIVE AND INSENSITIVE MICE, Pages 939-941, A. JORI, S. GARATTINI
EFFECTS OF d-AMPHETAMINE ON BODY TEMPERATURE AND ON BEHAVIORAL THERMOREGULATION IN RATS, Page 943, SHLOMO YEHUDA, RICHARD J. WURTMAN
THE METABOLISM AND EXCRETION OF ‘AMPHETAMINES’ IN MAN, Pages 945-950, J.W. GORROD
THE POSTSYNAPTIC EFFECT OF AMPHETAMINE ON STRIATAL DOPAMINE-SENSITIVE NEURONES, Pages 951-956, PAUL FELTZ, JACQUES DE CHAMPLAIN
ELECTROPHYSIOLOGICAL EFFECTS OF AMPHETAMINE ON DOPAMINERGIC NEURONS, Pages 957-962, BENJAMIN S. BUNNEY, GEORGE K. AGHAJANIAN
AMPHETAMINE AND NORADRENERGIC REWARD PATHWAYS, Pages 963-968, LARRY STEIN, C. DAVID WISE
OPERANT BEHAVIOURAL DEMONSTRATION OF QUALITATIVE DIFFERENCES BETWEEN THE d- AND l-ISOMERS OF AMPHETAMINE, Pages 969-972, S.B. SPARBER, D.W. PETERSON
DISSOCIATION OF AMPHETAMINE-INDUCED RELEASE OF NOREPINEPHRINE FROM INHIBITION OF NEURONAL UPTAKE IN ISOLATED BRAIN TISSUE, Pages 973-975, CHARLES O. RUTLEDGE, ALBERT J. AZZARO, RONALD J. ZIANCE
AMPHETAMINE AND METHYLPHENIDATE PSYCHOSIS, Pages 977-981, JOHN M. DAVIS, DAVID S. JANOWSKY
AMPHETAMINE METABOLISM IN AMPHETAMINE-INDUCED PSYCHOSIS, Pages 983-985, LARS-M. GUNNE M.D., ERIK ÄNGGÅRD M.D.
ON AMPHETAMINE TOLERANCE AND ABSTINENCE IN RATS, Pages 987-989, TOMMY LEWANDER, GULL MOLIIS, INGER BRUS
BEHAVIOURAL AND BIOCHEMICAL EFFECTS OF L-DOPA IN PSYCHIATRIC PATIENTS, Pages 991-994, BURTON M. ANGRIST M.D., GREGORY SATHANANTHAN, SAMUEL GERSHON, SHERWIN WILK
HALOGEN SUBSTITUTION OF AMPHETAMINE BIOCHEMICAL AND PHARMACOLOGICAL CONSEQUENCES, Pages 995-1001, F. SULSER, E. SANDERS-BUSH
NARCOTIC ANALGESICS AND THE REGULATION OF NEURONAL CATECHOLAMINE STORES, Pages 1003-1010, E. COSTA, A. CARENZI, A. GUIDOTTI, A. REVUELTA
EFFECT OF METHADONE ON BRAIN DOPAMINE METABOLISM, Pages 1011-1014, G.L. GESSA, L. VARGIU, G. BIGGIO, A. TAGLIAMONTE
EFFECTS OF SOME TETRAHYDROCANNABINOLS ON THE BIOSYNTHESIS AND UTILISATION OF CATECHOLAMINES IN THE RAT BRAIN, Pages 1015-1020, L. MAITRE, P.C. WALDMEIER, P.A. BAUMANN
ALCOHOL AND CATECHOLAMINE DISPOSITION: A ROLE FOR TETRAHYDROISOQUINOLINE ALKALOIDS, Pages 1021-1026, GERALD COHEN
ON THE POSSIBLE INTERRELATIONSHIP IN MECHANISM OF ACTION BETWEEN MORPHINE, AMPHETAMINE AND NEUROLEPTIC DRUGS, Pages 1027-1029, JØRGEN SCHEEL-KRÜGER
IMPORTANCE OF BRAIN DOPAMINE FOR THE STIMULANT ACTIONS OF AMPHETAMINE, Pages 1031-1034, K.E. MOORE, J.E. THORNBURG
p-HYDROXYNOREPHEDRINE: ITS SELECTIVE DISTRIBUTION IN DIFFERENT RAT BRAIN AREAS, Pages 1035-1037, F. CATTABENI, G. RACAGNI, A. GROPPETTI
THE EFFECT OF MORPHINE ON RAT BRAIN CATECHOLAMINES: TURNOVER IN VIVO AND UPTAKE IN ISOLATED SYNAPTOSOMES*, Pages 1039-1042, D.H. CLOUET, J.C. JOHNSON, M. RATNER, N. WILLIAMS, G.J. GOLD
PSYCHOPHARMACOLOGICAL PROFILE OF COCAINE, Pages 1043-1044, PIERRE SIMON
REPORTERS NOTES, Pages 1045-1049, SUSAN D. IVERSEN
CATECHOLAMINE METABOLITES IN CSF, Pages 1053-1054, BJÖRN-ERIK ROOS
METABOLITES OF CATECHOLAMINES IN THE CEREBROSPINAL FLUID, Pages 1055-1061, D.F. SHARMAN
SELECTIVE DEPLETION OF BRAIN REGIONAL NORADRENALINE BY SYSTEMIC 6-HYDROXYDOPAMINE IN NEWBORN RATS*, Pages 1063-1065, R. LAVERTY, M-C. LIEW, K.M. TAYLOR
VMA IN SPINAL FLUID: EVALUATION OF THE PATHWAYS OF CEREBRAL CATECHOLAMINE METABOLISM IN MAN, Pages 1067-1069, SHERWIN WILK, ERIC WATSON
OXYGEN-18 IN MEASUREMENT OF DOPAMINE TURNOVER IN RAT BRAIN, Pages 1071-1075, GORAN SEDVALL AVRAHAM MAYEVSKY, DAVID SAMUEL, CLAES-GÖRAN FRI
TECHNICAL STRATEGIES FOR THE STUDY OF CATECHOLAMINES IN MAN, Pages 1077-1082, DENNIS L. MURPHY
CYCLIC AMP AND A POSSIBLE ANIMAL MODEL OF RECEPTOR SUPERSENSITIVITY, Pages 1083-1084, D. ECCLESTON
APPLICATION OF MASS FRAGMENTOGRAPHY TO THE QUANTITATION OF ENDOGENOUS CATECHOLAMINES, Pages 1085-1090, STEPHEN H. KOSLOW
THE IDENTIFICATION OF DEPRESSED PATIENTS WHO HAVE A DISORDER OF NE METABOLISM AND/OR DISPOSITION, Pages 1091-1096, JAMES W. MASS, HAROUTUNE DEKIRMENJIAN, FRANK JONES
MONOAMINE NEURON SYSTEMS IN THE NORMAL AND SCHIZOPHRENIC HUMAN BRAIN: FLUORESCENCE HISTOCHEMISTRY OF FETAL, NEUROSURGICAL AND POST MORTEM MATERIAL, Pages 1097-1100, LARS OLSON, BO NYSTRÖM, ÅKE SEIGER
METABOLISM OF DOPAMINE AND L-DOPA IN HUMAN BRAIN, Pages 1101-1107, OLEH HORNYKIEWICZ
CHANGES IN HUMAN SERUM DOPAMINES-β-HYDROXYLASE ACTIVITY IN VARIOUS PHYSIOLOGICAL AND PATHOLOGICAL STATES, Pages 1109-1114, LEWIS S. FREEDMAN, MARK ROFFMAN, MENEK GOLDSTEIN
DOPAMINES-β-HYDROXYLASE ACTIVITY IN SERUM, Pages 1115-1121, RICHARD M. WEINSHILBOUM, FREDRICK A. RAYMOND, LILA R. ELVEBACK, WILLIAM H. WEIDMAN
PLASMA DOPAMINE-BETA-HYDROXYLASE IN IDENTICAL TWINS DISCORDANT FOR SCHIZOPHRENIA, Pages 1123-1126, FRIEDHELM LAMPRECHT, DENNIS L. MURPHY, RICHARD J. WYATT, ROBERT BELMAKER, WILLIAM POLLIN
CATECHOLAMINE METABOLISM AND NEUROLOGIC DISEASE, Pages 1127-1132, THOMAS N. CHASE
AMINES IN SCHIZOPHRENIA, Pages 1133-1138, SOLOMON H. SNYDER, SHAILESH P. BANERJEE
IMPLICATIONS OF FEEDBACK CONTROL IN CATECHOLAMINE NEURONAL SYSTEMS, Pages 1139-1142, STEVEN MATTHYSSE
INCREASED SERUM DOPAMINES-β-HYDROXYLASE ACTIVITY DURING NEUROGENIC HYPERTENSION IN QUADRIPLEGIA, Pages 1143-1147, EDWARD W. LOWMAN, N. ERIC NAFTCHI, JULIUS AXELROD, G. FREDERICK WOOTEN
HYPOTHALAMIC RELEASING HORMONES AND CATECHOLAMINES: A NEW INTERFACE, Pages 1149-1155, ARTHUR J. PRANGE JR., GEORGE R. BREESE, MORRIS A. LIPTON, IAN C. WILSON, PATRICIO P. LARA, NICHOLAS P. PLOTNIKOFF
AFFECTIVE DISORDERS: THE CATECHOLAMINE HYPOTHESIS REVISITED, Pages 1157-1164, FREDERICK K. GOODWIN, ROBERT L. SACK
CATECHOLAMINE METABOLISM AND AFFECTIVE DISORDERS: STUDIES OF MHPG EXCRETION, Pages 1165-1171, JOSEPH J. SCHILDKRAUT
COLLABORATIVE PSYCHOPHARMACOLOGIC STUDIES EXPLORING CATECHOLAMINE METABOLISM IN PSYCHIATRIC DISORDERS, Pages 1173-1179, BARON SHOPSIN, SAMUEL GERSHON, SHERWIN WILK, MARK ROFFMAN, MENEK GOLDSTEIN
REPORTER\'S NOTES, Pages 1181-1185, M.A. LIPTON
CLOSING REMARKS, Pages 1187-1188, MERTON SANDLER
INDEX, Pages 1189-1219